NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES
DOI:
https://doi.org/10.15407/exp-oncology.2025.04.467Keywords:
advanced cervical cancer, radical surgical treatment, symptomatic retroperitoneal lymphocyst, pelvic exenterationAbstract
Background. Cervical cancer (СС) continues to be the leading cancer pathology affecting women of both young and older ages. In the advanced stages of СС, the choice of treatment typically favors chemoradiotherapy. However, in a number of cases, radical surgery may be the only effective treatment. Th s issue requires further analysis. Materials and Methods. Five selected cases of the advanced СС (stages IIa—IVa) that required non-standard treatment are presented. Results. In all presented cases, the radical surgical treatment had an undeniable immediate curative effect. On follow-up, two patients are alive without any evidence of the disease; two patients died from disease progression and one patient is still receiving treatment for bone recurrence. Conclusions. Despite the fact that in most cases of advanced stages of СС, chemoradiotherapy is effectively used, in some selected cases, surgery may be leading and effective if the operation is performed in a radical manner. Important in this regard are the clinical experience, high level of surgical skills, presence of a multidisciplinary team, and the technical equipment of the medical center for performing such operations.
References
Chakrabarti M, Nordin A, Khodabocus J. Debulking hysterectomy followed by chemoradiotherapy versus chemo- radiotherapy for FIGO stage (2019) IB3/II cervical cancer. Cochrane Database Syst Rev. 2022;9(9):CD012246. https://doi.org/10.1002/14651858.CD012246.pub2
Conte C, Della Corte L, et al. Assessment of salvage surgery in persistent cervical cancer after definitive radioche- motherapy: a systematic review. Medicina (Kaunas). 2023;59(2):192. https://doi.org/10.3390/medicina59020192
Saemathong T, Chaowawanit W. A retrospective study of complications following pelvic and para-aortic lymphad- enectomy in gynecologic oncology. World J Oncol. 2024;15(3):423-431. https://doi.org/10.14740/wjon1824
Cibula D, Raspollini MR, Planchamp F, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer — Update 2023. Int J Gynecol Cancer. 2023;33(5):649-666. https://doi.org/10.1136/ijgc-2023-004429
Gupta S, Maheshwari A, Parab P, et al. Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol. 2018;36(16):1548-1555. https://doi.org/10.1200/JCO.2017.75.9985
Kenter GG, Greggi S, Vergote I, et al. EORTC-55994 Study Group. Randomized phase III study comparing neoad- juvant chemotherapy followed by surgery versus chemoradiation in stage IB2-IIB cervical cancer: EORTC-55994. J Clin Oncol. 2023;41(32):5035-5043. https://doi.org/10.1200/JCO.22.02852
Platt SL, Patel A, Humphrey PJ, et al. Completion surgery after chemoradiotherapy for cervical cancer — is there a role? UK Cancer Centre experience of hysterectomy post chemo-radiotherapy treatment for cervical cancer. J Obstet Gynaecol. 2019;39(1):68-73. https://doi.org/10.1080/01443615.2018.1463205
Yang J, Yang J, Cao D, et al. Completion hysterectomy after chemoradiotherapy for locally advanced adeno- type cervical carcinoma: updated survival outcomes and experience in post radiation surgery. J Gynecol Oncol. 2020;31(2):e16. https://doi.org/10.3802/jgo.2020.31.e16
Jiang W, Zhong ML, Wang SL, et al. Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis. World J Surg Oncol. 2024;22(1):262. https://doi.org/10.1186/s12957-024-03540-0
Lee JY, Kim Y, Lee TJ, et al. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in lo- cally advanced cervical cancer. J Gynecol Oncol. 2015 ;26(3):171-178. https://doi.org/10.3802/jgo.2015.26.3.171
Gold MA, Tian C, Whitney CW, et al. Surgical versus radiographic determination of para-aortic lymph node me- tastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer. 2008;112(9):1954-1963. https://doi.org/10.1002/cncr.23400
Marnitz S, Tsunoda AT, Martus P, et al. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study. Int J Gynecol Cancer. 2020;30(12):1855-1861. https://doi.org/10.1136/ijgc-2020-001973
Cosin JA, Fowler JM, Chen MD, et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 1998; 82(11):2241-2248. https://doi.org/10.1002/(sici)1097-0142(19980601) 82:11<2241::aid-cncr20>3.0.co;2-t
Khakimov GA, Khakimova GG. Results of pelvic exenteration in patients with cervical cancer: clinical experience.
J Modern Oncol. 2023;25(4):484-488. https://doi.org/10.26442/18151434.2023.4.202524
Bouraoui I, Bouaziz H, Tounsi N, et al. Survival after pelvic exenteration for cervical cancer. J Obstet Gynaecol India. 2022;72(1):66-71. https://doi.org/10.1007/s13224-021-01502-0
Graves S, Seagle BL, Strohl AE, et al. Survival after pelvic exenteration for cervical cancer: A National Cancer Data- base Study. Int J Gynecol Cancer. 2017;27(2):390-395. https://doi.org/10.1097/IGC.0000000000000884
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
